Physician profile
Christopher C Ninh
NPI 1700096393
$52,481.14
in general payments reported to CMS, 2019-2025
31 companies · $35K in 2025
The $35K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,365 · 2020: $4,111 · 2021: $461 · 2022: $1,292 · 2023: $2,258 · 2024: $1,761 · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $32K · Food and Beverage: $4,920 · Travel and Lodging: $1,932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $32,400.00 |
| Food and Beverage | $4,920.05 |
| Travel and Lodging | $1,932.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $33,552.61 | 2023-2025 | Venclose Maven Catheter |
| Advanced Orthopaedic Solutions, INC. | $9,900.00 | 2019-2020 | |
| Stryker Corporation | $3,196.03 | 2019-2025 | Mako, Gamma, Inspace |
| Depuy Synthes Sales INC. | $2,897.48 | 2019-2025 | Healix Knotless Peek, Vapr, Bristow Latarjet |
| Smith+Nephew, INC. | $764.76 | 2020-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Firstpass, Lens 4k |
| Encore Medical, Lp | $279.42 | 2022 | |
| Zimmer Biomet Holdings, INC. | $263.10 | 2019-2025 | Tapestry, Juggerknotless Soft Anchor, Samples Biologics |
| Globus Medical, INC. | $188.11 | 2022-2023 | Tibial Nail, Ankle Fracture System |
| Medacta USA, INC. | $176.93 | 2020-2022 | |
| Miach Orthopaedics, INC. | $160.45 | 2023 | |
| Ethicon US, LLC | $138.49 | 2020-2025 | Stratafix |
| Ferring Pharmaceuticals INC. | $117.34 | 2020-2023 | Euflexxa |
| Sonex Health, INC. | $112.60 | 2025 | Sx-One Microknife |
| Medtronic, INC. | $110.80 | 2024 | Venaseal |
| Fidia Pharma USA INC. | $87.04 | 2019-2023 | Triluron |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $72.64 | 2020-2021 | |
| Heraeus Medical, LLC. | $68.02 | 2022-2024 | Palacos |
| Horizon Therapeutics Plc | $56.47 | 2019-2022 | |
| Saxum Surgical, INC. | $48.54 | 2022-2023 | |
| Medartis INC. | $46.23 | 2020-2022 | |
| Organogenesis INC. | $41.34 | 2025 | Puraply Wound Matrix |
| Conformis, INC. | $37.99 | 2021 | |
| Micromed INC | $27.08 | 2021 | |
| Linvatec Corporation | $24.93 | 2019 | |
| Boston Scientific Corporation | $24.12 | 2024 | Varithena Administration Pack |
| Davol INC. | $19.70 | 2024 | Arista Ah Flexitip |
| Djo, LLC | $16.46 | 2019 | |
| Ermi LLC | $14.25 | 2019 | |
| Pacira Therapeutics, INC. | $14.22 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.05 | 2020 | |
| Convatec INC. | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ninh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.